Alcohol Research in HIV: Relapse Prevention

Description

3-arm type 1 pilot implementation-efficacy trial for people with alcohol use disorders to examine the preliminary effectiveness and feasibility of an adapted 2-session, computerized and person delivered relapse prevention intervention.

Conditions

HIV, Alcohol Use Disorder

Talk to us

Study Overview

On this page

Study Details

Study overview

3-arm type 1 pilot implementation-efficacy trial for people with alcohol use disorders to examine the preliminary effectiveness and feasibility of an adapted 2-session, computerized and person delivered relapse prevention intervention.

Alcohol Research Consortium in HIV: Relapse Prevention Arm

Alcohol Research in HIV: Relapse Prevention

Condition
HIV
Intervention / Treatment

-

Contacts and Locations

Baltimore

Johns Hopkins School of Medicine, Baltimore, Maryland, United States, 21287

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Confirmed diagnosis of HIV
  • * Aged 18 years or older
  • * Must be enrolled in clinical care at Johns Hopkins HIV Clinic.
  • 1. lifetime alcohol use disorder
  • 2. patient reported outcomes (PRO) assessment collected by the Center for AIDS Research (CFAR) Network of Clinical Systems as part of usual clinical care that show in the last 3 years: periods of no or lower risk drinking (e.g. women/men who are drinking \<11/22 drinks per week) and periods of lapse to higher levels of drinking (=\>11/22 drinks per week for women/men)
  • 3. current PRO showing alcohol abstinence or alcohol use at \<11/22 drinks per week for women/men.
  • * Acutely suicidal, homicidal, psychotic or otherwise unable to provide informed consent
  • * Non-English speaking because interventions are currently available in English only

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Johns Hopkins University,

Heidi Hutton, PhD, PRINCIPAL_INVESTIGATOR, Johns Hopkins School of Medicine

Study Record Dates

2026-05-31